Targeted Therapy for the Treatment of Advanced Non-small Cell Lung Cancer
- 1 December 2005
- Vol. 128 (6), 3975-3984
- https://doi.org/10.1378/chest.128.6.3975
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Targeting HER1/EGFR: A molecular approach to cancer therapySeminars in Oncology, 2003
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Second line chemotherapy for NSCLC: establishing a gold standardLung Cancer, 2002
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyJournal of Clinical Oncology, 2000
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995